BioCentury | Jan 20, 2014
Clinical News

Picato ingenol mebutate gel regulatory update

...2012 (see BioCentury, Dec. 3, 2012). Leo gained the product through its 2009 acquisition of Peplin...
BioCentury | Jul 15, 2013
Clinical News

Picato ingenol mebutate gel regulatory update

...year (see BioCentury, Dec. 3, 2012). Leo gained the product through its 2009 acquisition of Peplin...
BioCentury | Apr 22, 2013
Clinical News

Picato ingenol mebutate gel regulatory update

...year (see BioCentury, Dec. 3, 2012). Leo gained the product through its 2009 acquisition of Peplin...
BioCentury | Dec 3, 2012
Clinical News

Picato ingenol mebutate gel regulatory update

...Universitaetsmedizin Berlin (see BioCentury, Oct. 8). Leo gained the product through its 2009 acquisition of Peplin...
BioCentury | Nov 5, 2012
Finance

Asia-Pac expansion

...Fund I include dermatology company Peplin Inc. and autoimmune and cancer play Arana Therapeutics Ltd. Peplin...
BioCentury | Sep 24, 2012
Clinical News

Picato regulatory update

...in January (see BioCentury, Jan. 30). Leo gained the product through its 2009 acquisition of Peplin...
BioCentury | Jan 30, 2012
Clinical News

Picato regulatory update

...is an ingenol 3-angeloyl topical formulation. Leo gained the product through its 2009 acquisition of Peplin...
BioCentury | Jan 23, 2012
Emerging Company Profile

Dermira: Success is skin deep

...Inc. CEO Thomas Wiggans and CMO Eugene Bauer were both involved with Connetics Corp. and Peplin...
...five dermatology products to market (see BioCentury, Oct. 30, 2006) . The pair reconnected at Peplin...
BioCentury | Oct 21, 2011
Financial News

Dermira raises $42M in series A

...or acquire. Dermira's CEO is Tom Wiggans, who is the former chairman and CEO of Peplin...
...Inc. and former CEO of Connetics Corp. The CMO is Eugene Bauer, formerly CMO of Peplin...
BioCentury | Jun 20, 2011
Clinical News

PEP005 topical ingenol mebutate gel: Additional Phase III data

...PEP005 has been submitted for FDA review. Leo gained PEP005 through its 2009 acquisition of Peplin...
Items per page:
1 - 10 of 99
BioCentury | Jan 20, 2014
Clinical News

Picato ingenol mebutate gel regulatory update

...2012 (see BioCentury, Dec. 3, 2012). Leo gained the product through its 2009 acquisition of Peplin...
BioCentury | Jul 15, 2013
Clinical News

Picato ingenol mebutate gel regulatory update

...year (see BioCentury, Dec. 3, 2012). Leo gained the product through its 2009 acquisition of Peplin...
BioCentury | Apr 22, 2013
Clinical News

Picato ingenol mebutate gel regulatory update

...year (see BioCentury, Dec. 3, 2012). Leo gained the product through its 2009 acquisition of Peplin...
BioCentury | Dec 3, 2012
Clinical News

Picato ingenol mebutate gel regulatory update

...Universitaetsmedizin Berlin (see BioCentury, Oct. 8). Leo gained the product through its 2009 acquisition of Peplin...
BioCentury | Nov 5, 2012
Finance

Asia-Pac expansion

...Fund I include dermatology company Peplin Inc. and autoimmune and cancer play Arana Therapeutics Ltd. Peplin...
BioCentury | Sep 24, 2012
Clinical News

Picato regulatory update

...in January (see BioCentury, Jan. 30). Leo gained the product through its 2009 acquisition of Peplin...
BioCentury | Jan 30, 2012
Clinical News

Picato regulatory update

...is an ingenol 3-angeloyl topical formulation. Leo gained the product through its 2009 acquisition of Peplin...
BioCentury | Jan 23, 2012
Emerging Company Profile

Dermira: Success is skin deep

...Inc. CEO Thomas Wiggans and CMO Eugene Bauer were both involved with Connetics Corp. and Peplin...
...five dermatology products to market (see BioCentury, Oct. 30, 2006) . The pair reconnected at Peplin...
BioCentury | Oct 21, 2011
Financial News

Dermira raises $42M in series A

...or acquire. Dermira's CEO is Tom Wiggans, who is the former chairman and CEO of Peplin...
...Inc. and former CEO of Connetics Corp. The CMO is Eugene Bauer, formerly CMO of Peplin...
BioCentury | Jun 20, 2011
Clinical News

PEP005 topical ingenol mebutate gel: Additional Phase III data

...PEP005 has been submitted for FDA review. Leo gained PEP005 through its 2009 acquisition of Peplin...
Items per page:
1 - 10 of 99